secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-04-21T23:59:59+00:00
Accession:  0001575872-23-000592
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition receives Nasdaq deficiency notice for failing minimum public holders rule
--------------------------------------------------------------------------------

- Nasdaq notified TradeUP on April 19, 2023 it fails to meet minimum 300 public holders required by Listing Rule 5550(a)(3).
- Company has 45 calendar days to submit a compliance plan; extension of up to 180 days may be granted if plan accepted.
- Notice is a deficiency notification, not an immediate delisting; securities continue trading on Nasdaq Capital Market.
- If plan is not accepted, Company may appeal to a Nasdaq Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000592/0001575872-23-000592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000592/uptd-20220419.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer